Taylor Sandison's most recent trade in Cidara Therapeutics Inc was a trade of 166,836 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 30, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 166,836 | 166,836 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.64 per share. | 11 Sep 2024 | 924 | 23,067 (0%) | 0% | 11.6 | 10,752 | Common Stock |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 235,500 | 235,500 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 128,750 | 475,845 (1%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 11 Mar 2024 | 20,662 | 347,095 (0%) | 0% | 0.7 | 13,839 | Common Stock |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 180,000 | 180,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 90,000 | 378,550 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 13 Mar 2023 | 7,203 | 288,550 (0%) | 0% | 1.5 | 11,021 | Common Stock |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.68 per share. | 12 Sep 2022 | 18,478 | 291,753 (0%) | 0% | 0.7 | 12,656 | Common Stock |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 50,000 | 306,231 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 150,600 | 236,631 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 700 | 82,031 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Taylor Sandison | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 145,000 | 145,000 | - | - | Employee Stock Option (right to buy) |